Earnings Preview: Inhibikase Therapeutics By: Benzinga via Benzinga May 12, 2023 at 12:02 PM EDT Inhibikase Therapeutics (NASDAQ:IKT) is set to give its latest quarterly earnings report on Monday, 2023-05-15. Here's what investors ... Read More >> Related Stocks: Inhibikase Therapeutics Inc